Get the Stockscreener App
1.48
2.07%
0.03
Compugen Ltd stock is traded at $1.48, with a volume of 281.74K.
It is up +2.07% in the last 24 hours and down -14.45% over the past month.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
See More
Previous Close:
$1.45
Open:
$1.46
24h Volume:
281.74K
Relative Volume:
1.19
Market Cap:
$135.59M
Revenue:
-
Net Income/Loss:
$1.60M
P/E Ratio:
49.33
EPS:
0.03
Net Cash Flow:
$-62.91M
1W Performance:
-3.27%
1M Performance:
-14.45%
6M Performance:
-36.48%
1Y Performance:
-18.68%
1-Day Range:
$1.35
$1.4898
1-Week Range:
$1.35
$1.5498
52-Week Range:
$1.13
$2.66
Compugen Ltd Stock (CGEN) Company Profile
Compare CGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CGEN
Compugen Ltd
|
1.48 | 135.59M | 0 | 1.60M | -62.91M | 0.03 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Compugen Ltd Stock (CGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-13-25 | Initiated | Oppenheimer | Outperform |
| Aug-05-22 | Downgrade | Jefferies | Buy → Hold |
| May-26-20 | Resumed | JMP Securities | Mkt Outperform |
| May-13-20 | Initiated | Stifel | Buy |
| May-07-20 | Initiated | SVB Leerink | Outperform |
| Apr-22-20 | Initiated | ROTH Capital | Buy |
| Mar-24-20 | Initiated | SunTrust | Buy |
| Jan-16-20 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-29-18 | Initiated | Oppenheimer | Outperform |
| Feb-01-16 | Resumed | Oppenheimer | Outperform |
| Oct-15-15 | Initiated | FBR Capital | Outperform |
| Apr-23-15 | Resumed | Jefferies | Buy |
| Apr-21-15 | Initiated | Oppenheimer | Outperform |
| Feb-07-14 | Initiated | MLV & Co | Buy |
| Dec-28-09 | Reiterated | Cantor Fitzgerald | Buy |
| Jul-29-09 | Initiated | Cantor Fitzgerald | Buy |
View All
Compugen Ltd Stock (CGEN) Latest News
Compugen Ltd. stock retracement – recovery analysisForecast Model for Intraday Buy Signals - Newser
Using data tools to time your Compugen Ltd. exitLong-Term Allocation Strategy Summary Breakdown - Newser
Compugen Ltd. recovery potential after sell offLow Risk Strategy with Smart Entry Zones - Newser
Compugen Ltd. stock prediction for this weekFree Smart Money Tracking Signal Generator - Newser
Understanding Compugen Ltd.’s price movementRisk Shielded Trade Watch with Analysis - Newser
Real time scanner hits for Compugen Ltd. explainedFree Breakout Confirmation With Entry Tracker - Newser
Technical signs of recovery in Compugen Ltd.Free Daily Stock Market Swing Alerts - Newser
Compugen Ltd. stock momentum explainedFree Investment Strategy With Low Risk - Newser
Evaluating Compugen Ltd. with trendline analysisFree Consistent Income Focused Trade List - Newser
Why Compugen Ltd. stock attracts strong analyst attentionChart Signal and Short-Term Forecast Tracker - Newser
How Compugen Ltd. stock performs during market volatilityFree Weekly Top Gainers Forecast Watchlist - Newser
What are the latest earnings results for Compugen Ltd.Real Time Outlook With High Returns - jammulinksnews.com
How volatile is Compugen Ltd. stock compared to the marketFinancial News Tracker With High Returns - jammulinksnews.com
Using Bollinger Bands to evaluate Compugen Ltd.Real-Time AI Sentiment and Price Forecast - Newser
Advanced analytics toolkit walkthrough for Compugen Ltd.Pattern Recognition Based Market Move Prediction - Newser
Competitive Positioning of Compugen Ltd.: Is It Leading or LaggingAI Trade Signal Forecast with Chart Logic - Newser
What earnings revisions data tells us about Compugen Ltd.Swing Candidate List with Trade Cues - Newser
Intrinsic Value of Compugen Ltd. Stock: Is It Undervalued or OvervaluedFree Entry Plan for Oversold Reversal Stocks - Newser
Compugen Ltd. Company Revenue and Profit Trends: A Deep DiveStock Holding Strategy Long-Term Summary Sheet - Newser
Is Compugen Ltd. Stock a Smart Buy in 2025 Investment Analysis InsidePattern Detection for Entry Confirmation Enabled - metal.it
how compugen ltd. stock performs during market volatilityExit Strategy Guide With Risk Control Plan - Newser
What makes Compugen Ltd. stock price move sharplySmart Money Strategy for Growth Stocks - Newser
Compugen Ltd. Added to Custom Quant Screener TodayCapital Growth With Controlled Risk Picks Suggested - metal.it
Buy Signal for Compugen Ltd. Stock Key Technical Indicators to WatchLong-Term Signal Tracking and Profit Summary - Newser
Momentum Screeners Rank Compugen Ltd. in Top 5 TodayGrowth Based Stock Signal Screener Updated - metal.it
What candlestick patterns are forming on Compugen Ltd.Predicted Market Direction Based on Momentum - Newser
How to monitor Compugen Ltd. with trend dashboardsShort-Term Swing Opportunity Summary Sheet - Newser
How Efficient Is Compugen Ltd. at Controlling Operating CostsFree AI Trading Suggestions With Accuracy Focus - Newser
Trend Reversal Possible in Compugen Ltd. Charts IndicateDay Trading Signals With High Precision Reviewed - metal.it
How does Compugen Ltd. compare to its industry peersExpert Picks Planner For Fast Growth - jammulinksnews.com
Major Clinical Update: Compugen Reveals COM701 Phase 1 Data for Hard-to-Treat Ovarian Cancer at ESMO 2025 - Stock Titan
What are Compugen Ltd. company’s key revenue driversInvest confidently with actionable market data - jammulinksnews.com
What catalysts could drive Compugen Ltd. stock higher in 2025Consistently high yield - jammulinksnews.com
Why is Compugen Ltd. stock attracting strong analyst attentionHigh-profit capital plays - jammulinksnews.com
Is Compugen Ltd. a growth stock or a value stockAccelerated wealth expansion - jammulinksnews.com
Should I hold or sell Compugen Ltd. stock in 2025Consistently outstanding ROI - jammulinksnews.com
Is Compugen Ltd. stock overvalued or undervaluedOutstanding capital growth - jammulinksnews.com
Compugen Ltd Stock (CGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):